🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 17 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/12/2011 | 5,25 | 5,25 | 5,00 | 5,00 | -4,94% | 4,76% | 26.200 |
| 02/12/2011 | 5,45 | 5,45 | 5,26 | 5,26 | -2,95% | 3,49% | 8.000 |
| 01/12/2011 | 6,40 | 6,40 | 5,13 | 5,42 | -12,16% | 19,83% | 40.200 |
| 30/11/2011 | 5,60 | 6,49 | 5,60 | 6,17 | +10,18% | 15,89% | 69.000 |
| 29/11/2011 | 5,49 | 5,76 | 5,47 | 5,60 | +2,83% | 5,28% | 41.800 |
| 28/11/2011 | 5,15 | 5,45 | 5,15 | 5,45 | +6,16% | 5,83% | 18.400 |
| 25/11/2011 | 4,90 | 5,14 | 4,77 | 5,13 | +7,55% | 7,61% | 7.900 |
| 23/11/2011 | 4,90 | 5,00 | 4,75 | 4,77 | +0,21% | 5,10% | 20.800 |
| 22/11/2011 | 4,93 | 5,12 | 4,72 | 4,76 | +2,59% | 8,11% | 53.600 |
| 21/11/2011 | 5,50 | 5,50 | 4,30 | 4,64 | -16,09% | 21,82% | 105.700 |
| 18/11/2011 | 6,77 | 6,77 | 5,50 | 5,53 | -8,29% | 18,76% | 30.300 |
| 17/11/2011 | 5,72 | 6,38 | 5,53 | 6,03 | -6,51% | 14,86% | 25.700 |
| 16/11/2011 | 6,90 | 6,90 | 6,23 | 6,45 | -6,52% | 9,71% | 37.250 |
| 15/11/2011 | 6,70 | 6,93 | 6,12 | 6,90 | +2,99% | 12,09% | 58.660 |
| 14/11/2011 | 6,92 | 6,97 | 6,30 | 6,70 | +0,75% | 9,68% | 66.220 |
| 11/11/2011 | 8,19 | 8,20 | 6,29 | 6,65 | -11,33% | 23,32% | 147.860 |
| 10/11/2011 | 7,60 | 11,90 | 7,05 | 7,50 | +40,19% | 63,82% | 581.510 |
| 09/11/2011 | 5,50 | 5,80 | 5,13 | 5,35 | -2,73% | 12,18% | 22.710 |
| 08/11/2011 | 5,80 | 5,80 | 5,50 | 5,50 | -5,17% | 5,17% | 19.110 |
| 07/11/2011 | 6,00 | 6,00 | 5,72 | 5,80 | -2,68% | 4,67% | 11.380 |
| 04/11/2011 | 5,90 | 6,00 | 5,50 | 5,96 | +2,76% | 8,47% | 24.600 |
| 03/11/2011 | 5,65 | 5,90 | 5,60 | 5,80 | +3,57% | 5,31% | 20.560 |
| 02/11/2011 | 5,70 | 5,89 | 5,50 | 5,60 | +3,70% | 6,84% | 20.550 |
| 01/11/2011 | 5,40 | 5,65 | 5,02 | 5,40 | +7,14% | 11,67% | 32.740 |
| 31/10/2011 | 5,40 | 5,60 | 5,04 | 5,04 | -3,08% | 10,37% | 8.260 |
| 28/10/2011 | 5,40 | 5,40 | 5,12 | 5,20 | +3,17% | 5,19% | 18.450 |
| 27/10/2011 | 5,50 | 5,70 | 5,00 | 5,04 | -3,82% | 12,73% | 43.870 |
| 26/10/2011 | 5,70 | 5,70 | 5,00 | 5,24 | -2,96% | 12,28% | 30.290 |
| 25/10/2011 | 4,95 | 5,70 | 4,64 | 5,40 | +9,09% | 21,41% | 41.460 |
| 24/10/2011 | 4,70 | 5,50 | 4,60 | 4,95 | +7,61% | 19,15% | 59.720 |